Artelo Biosciences Inc. (ARTL) NASDAQ
$1.28 - (-)
Market Cap: $4.13M
As of 04/18/24 12:00 AM EDT. Market open.
Artelo Biosciences Inc. (ARTL)
NASDAQ
$1.28
- (-)
Market Cap: $4.13M
As of 04/18/24 12:00 AM EDT. Market open.
artelo biosciences is a biopharmaceutical company dedicated to applying true biopharma discipline in leveraging past research and leading-edge, world-class science to accelerate the development and commercialization of a diverse portfolio of novel, endocannabinoid system modulating therapeutics. our programs have the potential to dramatically improve patient care in major markets. with our ... read more
artelo biosciences is a biopharmaceutical company dedicated to applying true biopharma discipline in leveraging past research and leading-edge, world-class science to accelerate the development and commercialization of a diverse portfolio of novel, endocannabinoid system modulating therapeutics. our programs have the potential to dramatically improve patient care in major markets. with our headquarters team in san diego, california, usa and our european office in dublin, ireland, artelo established a presence in key global biopharma innovation hubs with close access to world-class research expertise. artelo’s research and development leverages the skill, knowledge and experience of our collaboration partners in europe and north america. read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Gorgas Gregory D. | Pres, CEO, CFO, Treas & Secr | Aug 12, 2022 | Buy | $4.00 | 1,200 | 4,800 | 2,400 | Aug 12, 2022, 05:41 PM |
Gorgas Gregory D. | Pres, CEO, CFO, Treas & Secr | Aug 11, 2022 | Buy | $4.03 | 1,200 | 4,836 | 1,200 | Aug 11, 2022, 07:13 PM |
Gorgas Gregory D. | Pres, CEO, CFO, Treas & Secr | Apr 16, 2021 | Buy | $1.15 | 8,500 | 9,809 | 270,676 | Apr 20, 2021, 04:10 PM |
Gorgas Gregory D. | Pres, CEO, CFO, Treas & Secr | May 15, 2020 | Buy | $1.21 | 4,200 | 5,072 | 262,176 | May 19, 2020, 05:45 PM |
MATSUI CONNIE | Director | May 04, 2020 | Buy | $1.20 | 41,667 | 50,000 | 56,667 | May 04, 2020, 09:34 PM |
Gorgas Gregory D. | Pres, CEO, CFO, Treas & Secr | May 04, 2020 | Buy | $1.20 | 4,167 | 5,000 | 257,976 | May 04, 2020, 09:33 PM |
Gorgas Gregory D. | Pres, CEO, CFO, Treas & Secr | Nov 04, 2019 | Buy | $2.21 | 2,400 | 5,304 | 253,809 | Nov 05, 2019, 04:10 PM |
Gorgas Gregory D. | Pres, CEO, CFO, Treas & Secr | Oct 31, 2019 | Buy | $1.95 | 2,500 | 4,875 | 248,909 | Nov 01, 2019, 05:40 PM |
Gorgas Gregory D. | Pres, CEO, CFO, Treas & Secr | Oct 30, 2019 | Buy | $1.99 | 2,600 | 5,186 | 246,409 | Nov 01, 2019, 05:40 PM |
Gorgas Gregory D. | Pres, CEO, CFO, Treas & Secr | Nov 01, 2019 | Buy | $2.28 | 2,500 | 5,702 | 251,409 | Nov 01, 2019, 05:40 PM |
Gorgas Gregory D. | Pres, CEO, CFO, Treas & Secr | Oct 15, 2019 | Buy | $2.05 | 2,600 | 5,333 | 243,809 | Oct 17, 2019, 06:47 PM |
Gorgas Gregory D. | Pres, CEO, CFO, Treas & Secr | Oct 11, 2019 | Buy | $1.96 | 2,700 | 5,296 | 241,209 | Oct 11, 2019, 08:29 PM |
Owner | Relationship | Date | Value($) |
Gorgas Gregory D. | Pres, CEO, CFO, Treas & Secr | 08/12/2022 | 4,800 |
Gorgas Gregory D. | Pres, CEO, CFO, Treas & Secr | 08/11/2022 | 4,836 |
Gorgas Gregory D. | Pres, CEO, CFO, Treas & Secr | 04/16/2021 | 9,809 |
Gorgas Gregory D. | Pres, CEO, CFO, Treas & Secr | 05/15/2020 | 5,072 |
MATSUI CONNIE | Director | 05/04/2020 | 50,000 |
Gorgas Gregory D. | Pres, CEO, CFO, Treas & Secr | 05/04/2020 | 5,000 |
Gorgas Gregory D. | Pres, CEO, CFO, Treas & Secr | 11/04/2019 | 5,304 |
Gorgas Gregory D. | Pres, CEO, CFO, Treas & Secr | 10/31/2019 | 4,875 |
Gorgas Gregory D. | Pres, CEO, CFO, Treas & Secr | 10/30/2019 | 5,186 |
Gorgas Gregory D. | Pres, CEO, CFO, Treas & Secr | 11/01/2019 | 5,702 |
Gorgas Gregory D. | Pres, CEO, CFO, Treas & Secr | 10/15/2019 | 5,333 |
Gorgas Gregory D. | Pres, CEO, CFO, Treas & Secr | 10/11/2019 | 5,296 |
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
GEODE CAPITAL MANAGEMENT, LLC | 19,808 | 0% | No change | Other |
Period of Report: 09/30/2023
10-K/10-Q Filings: View